Paul Foster

2.6k total citations
78 papers, 1.6k citations indexed

About

Paul Foster is a scholar working on Religious studies, Oncology and Sociology and Political Science. According to data from OpenAlex, Paul Foster has authored 78 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Religious studies, 21 papers in Oncology and 17 papers in Sociology and Political Science. Recurrent topics in Paul Foster's work include Biblical Studies and Interpretation (26 papers), Historical and Linguistic Studies (17 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Paul Foster is often cited by papers focused on Biblical Studies and Interpretation (26 papers), Historical and Linguistic Studies (17 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Paul Foster collaborates with scholars based in United States, United Kingdom and Australia. Paul Foster's co-authors include Robert M. Stroud, Koho Iizuka, John D. Powderly, Roel Funke, Janet Finer-Moore, Daniel V. Santi, Rajesh S. Gokhale, Julian C.‐H. Chen, David E. Cane and Larry J. W. Miercke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Paul Foster

60 papers receiving 1.5k citations

Peers

Countries citing papers authored by Paul Foster

Since Specialization

Citations

This map shows the geographic impact of Paul Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Foster more than expected).

Fields of papers citing papers by Paul Foster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Foster. The network helps show where Paul Foster may publish in the future.

Co-authorship network of co-authors of Paul Foster

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Foster. A scholar is included among the top collaborators of Paul Foster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Foster. Paul Foster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetics, pharmacodynamics and safety of casdatifan, a novel hypoxia‐inducible factor‐2α inhibitor, in healthy participants 2025 ·British Journal of Clinical Pharmacology ·Mohammad Ghasemi, Ji Yun Kim, Lisa Seitz, Lixia Jin, Paul Foster, Ken Liao, Tzuling Cheng, Elaine Paterson, Maria Velinova, (unknown), Reza Khosravan, Balaji Agoram	0
2	Casdatifan (Cas) monotherapy in patients (pts) with previously treated clear cell renal cell carcinoma (ccRCC): Safety, efficacy and subgroup analysis across multiple doses from ARC-20, a phase 1 open-label study. 2025 ·Journal of Clinical Oncology ·Toni K. Choueiri, Jae‐Lyun Lee, Jaime R. Merchan, Amita Patnaik, (unknown), Alexandra Drakaki, Moshe Chaim Ornstein, Bradley A. McGregor, Ralph J. Hauke, (unknown), Brian I. Rini, Pedro C. Barata, Paul Foster, Sutapa Mukhopadhyay, (unknown), (unknown), Manish Monga, Dimitry S.A. Nuyten, Sun Young Rha	0
3	Fc-Silent Anti-TIGIT Antibodies Potentiate Antitumor Immunity without Depleting Regulatory T Cells 2024 ·Cancer Research ·(unknown), Amber E. de Groot, Soonweng Cho, (unknown), Rebecca D. Ray, Amita Patnaik, Paul Foster, (unknown), (unknown), Wandi S. Zhu, (unknown), Hema Singh, Xiaoning Zhao, Lisa Seitz, Nigel P.C. Walker, Matthew J. Walters, Kelsey E. Sivick	8
4	MA15.02 Long-Term Safety and Clinical Activity Results from a Phase Ib Study of Erlotinib Plus Atezolizumab in Advanced NSCLC 2018 ·Journal of Thoracic Oncology ·Charles M. Rudin, Andrés Cervantes, Afshin Dowlati, Benjamin Besse, Brigette Ma, Daniel B. Costa, Peter Schmid, Rebecca S. Heist, Victoria Villaflor, Indrani Sarkar, Genevive Hernandez, Paul Foster, Jessica Spahn, Carol O’Hear, Scott Gettinger	26
5	P3.02c-046 Safety, Clinical Activity and Biomarker Results from a Phase Ib Study of Erlotinib plus Atezolizumab in Advanced NSCLC 2017 ·Journal of Thoracic Oncology ·Charles M. Rudin, Andrés Cervantes, Afshin Dowlati, Benjamin Besse, Brigette Ma, Daniel B. Costa, Peter Schmid, Rebecca S. Heist, Victoria Villaflor, Indrani Sarkar, Mahrukh Huseni, Paul Foster, Carol O’Hear, Scott Gettinger	11
6	Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study 2017 ·Annals of Oncology ·Robin Kate Kelley, Chris Verslype, Allen Lee Cohn, T.-S. Yang, Wu‐Chou Su, Howard A. Burris, Fadi Braiteh, Nicholas J. Vogelzang, Alexander I. Spira, Paul Foster, (unknown), Eric Van Cutsem	109
7	A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma 2017 ·European Journal of Cancer ·Ignace Vergote, David C. Smith, Raanan Berger, Razelle Kurzrock, Nicholas J. Vogelzang, Avishay Sella, Jennifer J. Wheler, (unknown), Paul Foster, (unknown), Ronald J. Buckanovich	29
8	Efficacy and safety of cobimetinib (cobi) and atezolizumab (atezo) in an expanded phase 1b study of microsatellite-stable (MSS) metastatic colorectal cancer (mCRC) 2016 ·Annals of Oncology ·Jayesh Desai, Yong Sang Hong, (unknown), T.W. Kim, Sae‐Won Han, Y-J. Bang, (unknown), (unknown), Autumn J. McRee, Laura Q.M. Chow, E.L. Kwak, Jeffrey R. Infante, Johan Wallin, Meghna Das Thakur, (unknown), Paul Foster, Edward Cha, Johanna C. Bendell	5
9	441O Preliminary safety and clinical activity of erlotinib plus atezolizumab from a Phase Ib study in advanced NSCLC 2016 ·Annals of Oncology ·Brigette Ma, Charles M. Rudin, Andrés Cervantes, Afshin Dowlati, Daniel B. Costa, Peter Schmid, Rebecca S. Heist, (unknown), Indrani Sarkar, Mahrukh Huseni, Paul Foster, Carol O’Hear, Scott Gettinger, Benjamin Besse	35
10	Memory, Orality, and the Fourth Gospel: Three Dead-Ends in Historical Jesus Research 2012 ·Paul Foster	4
11	Potentiating the antitumor effects of chemotherapy with the selective PI3K inhibitor XL147 2007 ·Molecular Cancer Therapeutics ·Paul Foster	12
12	Ah Q Archaeology 2006 ·Lexington Books ·Paul Foster	3
13	High-Throughput Structural Biology in Drug Discovery: Protein Kinases 2004 ·Current Pharmaceutical Design ·Thomas J. Stout, Paul Foster, David J. Matthews	38
14	Crystal structure of the macrocycle-forming thioesterase domain of the erythromycin polyketide synthase: Versatility from a unique substrate channel 2001 ·Proceedings of the National Academy of Sciences ·Shiou‐Chuan Tsai, Larry J. W. Miercke, J. Krucinski, Rajesh S. Gokhale, Julian C.‐H. Chen, Paul Foster, David E. Cane, Chaitan Khosla, Robert M. Stroud	179
15	The structural basis for tRNA recognition and pseudouridine formation by pseudouridine synthase I. 2000 ·Nature Structural Biology ·Robert M. Stroud, Paul Foster, Lixuan Huang, (unknown)	76
16	Mechanism-Based Inhibition of Thymidylate Synthase by 5-(Trifluoromethyl)-2'-deoxyuridine 5'-Monophosphate 1994 ·Biochemistry ·(unknown), Paul Foster, Janet Finer-Moore, Yusuke Wataya, Daniel V. Santi	47
17	Radiotherapy for parotid cancer 1994 ·Annals of Surgical Oncology ·Leonard M. Toonkel, (unknown), Paul Foster, Victor D. Dembrow	15
18	Construction of a dihydrofolate reductase-deficient mutant of Escherichia coli by gene replacement 1988 ·Journal of Bacteriology ·Elizabeth E. Howell, Paul Foster, Lyndon M. Foster	50
19	Predictability of sequence homologies among lysine-rich histones by immunological distance 1987 ·Comparative Biochemistry and Physiology Part B Comparative Biochemistry ·(unknown), Paul Foster, J. M. Neelin	2
20	White to move? : a portrait of East Africa today 1961 ·Paul Foster	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact